IHC: Immunohistochemistry; NSCLC: Non-small-cell lung cancer. Adapted with permission from [77]. The authors have no relevant affiliations or financial involvement with any organization or entity with ...
The Global DNA Sequencing Market was valued at USD 14.8 Billion in 2024, and is expected to reach USD 34.8 Billion by 2029, rising at a CAGR of 18.60%. The report highlights the current and future ...
Genotypic testing is recommended as the preferred resistance testing method to guide therapy in antiretroviral-naive and antiretroviral-experienced persons. A major limitation of clinically available ...
Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and processed, could trigger malware in sequencing software. When a vulnerability in ...